Rosenthal S, Chen R
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA.
Am J Public Health. 1995 Dec;85(12):1706-9. doi: 10.2105/ajph.85.12.1706.
To evaluate reporting sensitivities for vaccine adverse events, reporting rates were estimated by dividing the number of events reported to the Monitoring System for Adverse Events Following Immunization and the Vaccine Adverse Event Reporting System in a given period by the number of doses administered or distributed during the same period. Reporting sensitivity was calculated as the ratio of the rates at which events were reported to each passive surveillance system (numerator) and occurred in controlled studies (denominator). Reporting sensitivities were generally better in the public sector than in the private sector. The significant underreporting of known outcomes, together with the nonspecific nature of most adverse event reports, highlights the limitations of passive surveillance systems in assessing the incidence of vaccine adverse events.
为评估疫苗不良事件的报告敏感性,通过将特定时期内向免疫接种后不良事件监测系统和疫苗不良事件报告系统报告的事件数量除以同期接种或分发的剂量数来估计报告率。报告敏感性计算为每个被动监测系统报告事件的发生率(分子)与对照研究中发生事件的发生率(分母)之比。公共部门的报告敏感性通常优于私营部门。已知结果的大量漏报,以及大多数不良事件报告的非特异性,凸显了被动监测系统在评估疫苗不良事件发生率方面的局限性。